Chromatography used in vaccine development
Scientists used chromatography to develop a potential vaccine against CHIKV

GC, MDGC

Chromatography used in vaccine development

19 Jul, 2011

Published over 15 years ago. See the latest and most current information on GC, MDGC.

Scientists have used chromatography methods to identify a possible vaccine for the prevention of chikungunya virus (CHIKV) infections, Virology Journal reported.

CHIKV is a mosquito-borne virus which is responsible for a number of large epidemics in Africa, south-east Asia and India, with invading Asian tiger mosquitoes now thought to have spread the infection to southern Europe.

After an incubation period of two to six days, patients display symptoms including joint pain, vomiting and nausea, headaches, chills and fever as well as a rash across the body.

In recent epidemics, mortality rates are thought to be as high as 33 per cent as the virus often targets the over 65s.

Using methods including metal affinity chromatography, scientists studied the CHIKV envelope proteins E1 and E2 to develop a vaccine against the virus.

"The ability of purified, secreted CHIKV-E2 to induce neutralising antibodies in rabbits underscores the potential use of E2 in a subunit vaccine to prevent CHIKV infections," the report stated.

Explore Our Other Sites

Labmate Online
Metrohm launches OMNIS IC: a new benchmark in ion chromatography
Explore more Arrow
Envirotech Online
Phenol on the ground: what a COMAH prosecution shows about soil data as evidence
Explore more Arrow
Pollution Solutions Online
Pump and mixer service at paper mill set to reach 40 years
Explore more Arrow
Petro Online
Hydrogen sulphide deaths expose the gaps in gas detection during non-routine work
Explore more Arrow